Wegovy images: what the pen, packaging and injection actually look like

Wegovy comes as a pre-filled injection pen — each pen delivers one weekly dose, and you receive one pen per prescription week.
Pens are colour-coded by strength (0.25 mg through to 2.4 mg, and now a dedicated 7.2 mg single-dose pen approved by the MHRA in April 2026).
The needle is very short and fine; the injection is subcutaneous (just under the skin), not into a vein or muscle.
Wegovy must be stored in a refrigerator between 2°C and 8°C — check the Patient Information Leaflet for exact room-temperature guidance if you need to travel.

Wegovy is a pre-filled, once-weekly injection pen containing semaglutide, made by Novo Nordisk. Each pen is single-use, comes in a range of colour-coded strengths, and is dispensed in a small cardboard outer carton. If you've been searching for wegovy images to understand what arrives through the post or what the injection process involves, the honest answer is straightforward: it looks much like any other modern auto-injector. Wegovy is a semaglutide medicine, and like all prescription-only weight-loss injections it can only be dispensed following a clinical assessment by a qualified prescriber.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

The full picture: pen design, dose markings, packaging and what the injection actually involves

The biggest misconception: Wegovy looks far more intimidating in your imagination than in your hand

Most people searching for images of Wegovy are doing so because they're nervous. That's completely understandable, the idea of injecting yourself at home, week after week, trips a lot of people up before they've even filled a prescription. The misconception is that GLP-1 pens resemble the large, clinical syringes you might associate with a hospital ward. They don't. Wegovy uses a compact auto-injector roughly the size of a thick marker pen. You press the cap end against your skin, press the button, and the needle (which is very short and fine) does its work without you seeing it at all. The injection itself takes only a few seconds.

Novo Nordisk designed the device so that the needle is hidden inside the tip both before and after use. There's an audible click when the dose starts and a second when it's complete. Many people are surprised by how undramatic the process is. If you've ever watched someone use an EpiPen, the mechanism is conceptually similar, though the pens are smaller and the force is gentler. For a closer look at how the appearance of the face and body can change over a course of treatment, our page on Wegovy face images covers what the clinical evidence says about visible changes.

What's inside the box: carton, pen, needle cap and instructions

When Wegovy is dispensed by a GPhC-registered pharmacy like ours, it arrives in a plain outer box, nothing on the outside identifies it as a weight-loss medicine. Inside, you'll find the cardboard carton from the manufacturer, which contains the pre-filled pen, a capped needle tip already attached, and the Patient Information Leaflet. The pens are colour-banded: each strength has its own distinct colour on the label and the dial area, which matters because the dose titration schedule moves through several steps across many months. The stages of Wegovy involve gradually increasing the dose; having that colour-coding is a simple visual check that you're using the right pen at the right stage.

The pen body itself is white or off-white plastic, with a small window that lets you confirm the liquid inside is clear and colourless before you inject. If it's cloudy, discoloured, or contains particles, the leaflet advises you not to use it and to contact your pharmacy. Storage is in the refrigerator between 2°C and 8°C, think of it as living in the fridge door, much like an insulin pen. If you're looking at the cost of the treatment alongside what you're receiving physically, our Wegovy cost page breaks down what a private prescription typically includes.

The new 7.2 mg pen: what's different visually and mechanically

In April 2026 the MHRA approved a dedicated single-dose 7.2 mg Wegovy pen, the first at that strength to be dispensed as one weekly injection rather than three 2.4 mg pens. According to the government's announcement of the single-dose 7.2 mg pen approval, the new device has an auto-dosing mechanism, a built-in covered needle, and locks automatically after use. It is approved only for adults with a BMI of 30 or above and cannot be used for the cardiovascular indication. Visually it is slightly different from the lower-dose pens, the lock-after-use mechanism means the tip is non-retractable once fired, which is relevant for safe disposal. Always use an appropriate sharps container rather than a household bin.

The 7.2 mg dose is the maximum in the Wegovy titration schedule. Patients don't begin there, the starting dose remains 0.25 mg, moving upward in steps under prescriber supervision. If you're curious about how that progression works in practice, the Wegovy dose stages page covers the schedule in detail. Whether you'd ever reach 7.2 mg, and in which pen format, is something a prescriber would confirm at review. It's worth knowing the option exists, but the right stage for you depends entirely on clinical judgment.

A word on images you find online: quality varies enormously

One reason people search specifically for Wegovy images is that the pictures circulating on social media and forums are often photos of counterfeit pens, stock imagery of unrelated syringes, or pictures of Ozempic (a different semaglutide product licensed for type 2 diabetes, not weight loss, the two are commonly confused). The MHRA has warned publicly about fake weight-loss pens sold without a valid prescription, and counterfeit products can look almost identical to genuine ones at a glance. The safest way to know exactly what a genuine Wegovy pen looks like is to receive one dispensed by a pharmacy you can verify on the GPhC pharmacy register. If you're considering treatment and want to understand the full picture first (including the disadvantages of Wegovy that don't always make it into promotional material) a free consultation is the right place to start. Our prescribers answer these questions every day, before 12pm if you want your prescription reviewed the same afternoon.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions